Who we are
At Kelso Pharma, our vision is to bring innovative, value added, specialty medicines to the European healthcare markets. Medicines that provide meaningful benefits to patients and create added value for healthcare stakeholders.
We plan to enhance value for the healthcare system by providing medicines that improve the lives of patients in a cost-effective way and we are committed to behaving in an ethical manner in everything that we do.
We will build Kelso Pharma through a blend of company & product acquisitions, partnerships and organic growth, both in the UK and in Europe. We are focused on creating a positive, entrepreneurial working environment for our people, because a happy team creates value – for patients, the healthcare system and the business.
The company is backed by Apposite Capital LLP, a private equity firm specialising in investing in SME businesses in healthcare. The Kelso pharma team has extensive experience in growing and running a specialty pharma business across Europe.
We will focus on providing branded medicines that meet the needs of patients and are affordable for the healthcare system. Providing medicines that are easier to take improves patient compliance, delivering greater value to the healthcare system.
We will encourage and focus on innovation, and we will ensure that security of the supply of our medicines is a primary focus for the business, enabling our medicines to be made available to patients when and where they need them.